Nabilone for Non-motor Symptoms in Parkinson's Disease
NCT03769896
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
48
Enrollment
OTHER
Sponsor class
Conditions
Parkinson Disease
Interventions
DRUG:
Nabilone 0.25 mg
DRUG:
Placebo
Sponsor
Medical University Innsbruck